EUVIMEDEUVIMED entdecken
Crossref

β-Sitosterol-loaded leciplexes attenuate rheumatoid arthritis in rats by modulating JAK2/STAT3, NF-κB, and p38 MAPK signaling pathways

Fatma M Mady, Alyaa Alsalhi, Randa Mohammed Zaki, Mohamed M Nafady, Heba M Aboud, Abdallah Z Zayan, Mostafa A Darwish, Amal K Hussein

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-06 · 399 (9) · 14315-14338

DOI: 10.1007/s00210-026-05270-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 15.04.2026. Verfasst von Fatma M Mady und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, 61519, Egypt. Hauptthemen laut MEDLINE: Arthritis, Experimental, Sitosterols, Arthritis, Rheumatoid, Anti-Inflammatory Agents. Die Arbeit nennt 97 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by persistent synovial hyperplasia, progressive osteoarticular destruction, and systemic inflammatory complications. β-Sitosterol (BSS), a plant-derived phytosterol, exhibits anti-inflammatory and antioxidant properties; however, its therapeutic utility is limited by poor aqueous solubility and low oral bioavailability. This study aimed to enhance the oral delivery of BSS using Leciplex nanocarriers (BSS-LPXs) and to investigate their effects on key inflammatory pathways in Complete Freund's Adjuvant (CFA)-induced RA in rats. BSS-LPXs were optimized using a Box-Behnken design to achieve optimal vesicle size, entrapment efficiency, and sustained drug release. Pharmacokinetic parameters were assessed following oral administration in rats. Anti-arthritic pharmacodynamics were evaluated via clinical arthritis scoring, serum cytokine levels (TNF-α, IL-6), oxidative stress markers (GSH, SOD, MDA), and histopathological examination. Mechanistic studies focused on the modulation of JAK2/STAT3, NF-κB, and p38 MAPK signaling pathways. Optimized BSS-LPXs had an average size of ~ 146 nm, 66% entrapment efficiency, and sustained release characteristics. Oral administration of BSS-LPXs significantly increased bioavailability by 3.8-fold compared to the conventional suspension (p < 0.05), with higher Cmax and prolonged half-life. In vivo, BSS-LPXs attenuated arthritis progression, preserved body weight, lowered TNF-α and IL-6 levels, restored antioxidant defenses, and decreased lipid peroxidation. Mechanistically, the formulation downregulated JAK2/STAT3 expression and suppressed the activation of NF-κB and p38 MAPK signaling. Histopathological analysis confirmed reduced synovial hyperplasia and cartilage damage. Leciplexes improved oral bioavailability and systemic exposure of BSS compared with conventional suspension, while enhancing anti-arthritic efficacy by modulating key inflammatory pathways, reducing oxidative stress, and protecting joint structure. This combined pharmacokinetic and pharmacodynamic profile highlights the potential of LPXs as an effective strategy to improve the delivery and anti-arthritic activity of hydrophobic phytoconstituents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, ExperimentalSitosterolsArthritis, RheumatoidAnti-Inflammatory AgentsAnimalsSTAT3 Transcription FactorJanus Kinase 2p38 Mitogen-Activated Protein KinasesNF-kappa BMaleSignal TransductionLiposomesAdministration, OralRats, Sprague-DawleyRatsFreund's AdjuvantCytokines

Stichwörter der Autor:innen

JAK2/STAT3LeciplexesP38 MAPK/NF-κBPharmacokineticsRheumatoid arthritisβ-Sitosterol

Substanzen

STAT3 Transcription FactorJanus Kinase 2p38 Mitogen-Activated Protein KinasesNF-kappa BStat3 protein, ratSitosterolsJak2 protein, ratgamma-sitosterolLiposomesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, 61519, Egypt.
  • Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451, Saudi Arabia. asalsalhi@ksu.edu.sa.
  • Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj, 11942, Saudi Arabia.
  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt.
  • Department of Pharmaceutics, Faculty of Pharmacy, Nahda University, Beni-Suef, 62513, Egypt.
  • Department of Pharmaceutics, Faculty of Pharmacy, Almaaqal University, Basrah, 61014, Iraq. abdallah.zidan.zayan@almaaqal.edu.iq.

Zitieren

APA

Mady, F. M., Alsalhi, A., Zaki, R. M., Nafady, M. M., Aboud, H. M., Zayan, A. Z., Darwish, M. A., & Hussein, A. K. (2026). β-Sitosterol-loaded leciplexes attenuate rheumatoid arthritis in rats by modulating JAK2/STAT3, NF-κB, and p38 MAPK signaling pathways. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(9), 14315-14338. https://doi.org/10.1007/s00210-026-05270-4

Vancouver

Mady FM, Alsalhi A, Zaki RM, Nafady MM, Aboud HM, Zayan AZ, et al. β-Sitosterol-loaded leciplexes attenuate rheumatoid arthritis in rats by modulating JAK2/STAT3, NF-κB, and p38 MAPK signaling pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(9):14315-14338. doi:10.1007/s00210-026-05270-4

BibTeX
@article{Mady2026,
  author = {Mady, Fatma M and Alsalhi, Alyaa and Zaki, Randa Mohammed and Nafady, Mohamed M and Aboud, Heba M and Zayan, Abdallah Z and Darwish, Mostafa A and Hussein, Amal K},
  title = {β-Sitosterol-loaded leciplexes attenuate rheumatoid arthritis in rats by modulating JAK2/STAT3, NF-κB, and p38 MAPK signaling pathways},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {9},
  pages = {14315--14338},
  doi = {10.1007/s00210-026-05270-4}
}
Kostenlos starten →